fda compounding glp-1 warning letters october 2025 Compounded GLP-1s: Why doctors worry and the is cracking down fda glp-1 warning letters october

The FDAs drug information label now includes severe pancreatitis and severe kidney injuries

While some BCBS plans may still cover Wegovy, a growing number of BCBS affiliates have dropped, restricted, or significantly raised the cost of GLP-1 weight-loss medications

doi: 10.1530/eje.0.1330425 128 FrieboesMurckAntonijevicSteiger

This is not a set-it-and-forget-it transition it requires close monitoring and ideally a care team experienced in adjusting insulin regimens

GLP-1 Guide Evidence-first GLP-1 drugs and research compounds like semaglutide, tirzepatide, and retatrutide curb appetite, which can leave gaps in protein and key nutrients

Okra polysaccharides alleviation of oxidative stress and neuroinflammation (Yan et al., 2021) in high-fat-diet (HFD) induced oxidative stress